acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 12 Apr 2021 Notice of Annual General Meeting in Acarix AB Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 07 Apr 2021 Positive, long term prognostic data from the Dan-NICAD I study published in European Heart Journal- Digital Health Press releaseMalmö, Sweden, April 7, 2021 Positive, long term... Continue reading
acarix English, Interim, IR, MAR, News, Regulatory, Report, Yearend November 18, 2024 18 Feb 2021 A strong ending of an eventful year Press release (MAR) Malmö, February 18, 2021 Acarix AB (publ) publishes Year-End Report 2020 A strong ending of an eventful yea... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 13 Jan 2021 Positive preliminary data from Acarix’s exploratory heart failure study SEISMO &nb... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 09 Dec 2020 Acarix announces the last patient included in Dan-NICAD II study Press release Malmö, Sweden December 9, 2020 Acarix announces the last patient included in Dan-NICAD II study After the inclusi... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 26 Nov 2020 FDA identifies exclusive code for the CADScor® Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor® After yesterday’s a... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 25 Nov 2020 Acarix receives US market approval for the CADScor® System Press release (MAR)Malmö, Sweden November 25, 2020 Acarix receives US market approval for the CADScor® System Acarix AB (pu... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 18 Nov 2020 Positive results from Acarix study presented at ISPOR, a leading health economics conference Press releaseMalmö, Sweden November 18, 2020 Positive results from Acarix study presented at ISPOR, a leading health economics co... Continue reading
acarix English, Interim, IR, MAR, News, Q3, Regulatory, Report November 18, 2024 12 Nov 2020 Correction: Interim report 2020-01-01 to 2020-09-30 Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Ac... Continue reading
acarix English, Interim, IR, MAR, News, Q3, Regulatory, Report November 18, 2024 12 Nov 2020 A Successful Rights Issue with Focus on Sales! Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Success... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Oct 2020 Acarix changes Certified Advisor to Redeye Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB (publ) announces t... Continue reading
acarix Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares November 18, 2024 29 Sep 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with th... Continue reading